傳遞娛樂(01326.HK)預計中期虧損7500萬至8000萬港元
格隆匯2月10日丨傳遞娛樂(01326.HK)發佈公吿,相比2019年相應中期期間公司擁有人應占淨虧損約港幣1958.6萬元,公司預計截至2020年12月31日止六個月錄得公司擁有人應占淨虧損為約港幣7500萬元至港幣8000萬元之間。
此乃主要由於受到新冠疫情的影響,市場氣氛於中期期間持續疲弱,以致電影放映業務收入大幅下降;及2019年相應中期期間錄得若干影視版權出售收益,而中期期間沒有錄得這部分收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.